Jocelyn D Spates

Pharmacy Building Room 312
Tuesdays 1:00pm-2:00pm

PHA 3884 Pharmacy Forum and Colloquium Tu - 11:00 a.m. - 11:50 a.m.
PHA 4886 Pharmacy Forum and Colloquium Tu - 11:00 a.m. - 11:50 a.m.
PHA 5888 Pharmacy Forum and Colloquium Tu - 11:00 a.m. - 11:50 a.m.
PHA 3885 Pharmacy Forum and Colloquium Tu - 11:00 a.m. - 11:50 a.m.
PHA 4887 Pharmacy Forum anc Colloquium Tu - 11:00 a.m. - 11:50 a.m.
PHA 5889 Pharmacy Forum and Colloquium Tu - 11:00 a.m. - 11:50 a.m.

---

---

Dr. Jocelyn D. Spates is a Professor of Pharmacy Practice at Florida A&M University College of Pharmacy and Pharmaceutical Sciences, Institute of Public Health. Additionally, she holds the title of Associate Dean of Clinical Affairs. She received her Bachelor of Science degree in Pharmacy from Florida A&M University and Doctor of Pharmacy degree from Idaho State University. Dr. Spates joined the faculty in 2003 after serving as a preceptor for the Northeast Florida Pharmacy Practice Center (Jacksonville). She is a board-certified pharmacotherapy specialist (BCPS) and an American Association of Colleges of Pharmacy Academic Leadership Fellow. She has received the Teacher of the Year award twice and the Dean’s Appreciation Award. She has published numerous articles and presented posters at national pharmacy meetings.

---

---

• Pharmacotherapy
  
• Leadership Development
  
• Accreditation

---

---

---

---

• Associate Dean of Clinical Affairs October 2014-Present
  Florida A&M University College of Pharmacy and Pharmaceutical Sciences, Institute of Public Health
• Assistant/Associate Professor of Pharmacy Practice January 2003- October 2014
  Florida A&M University College of Pharmacy and Pharmaceutical Sciences, Institute of Public Health, Jacksonville Instructional Site

---

---

•  Johnson SA, Spates JD, Smith UD, Harris CM, Simmons M et al. COVID-19 Vaccine Hesitancy among People of Color: Meeting the Needs in Florida. ABNFF. Volume 1 2 (2023), Number 1.
  
• Mathis A, Spates J, Suther S. Developing Medication Therapy Management Training
  for Community Health Professionals Serving Low-Income Patients. J. Pharm. Prac. April 5, 2022. https://doi.org/10.1177/08971900221077610
  
• New Drug Overview: Aducanumab-Avwa (Aduhelm) for Alzheimer Disease Smith NC, Burroughs TC, Gaspard PH, Okonkwo NP, Tran DP, Walters PV, Spates JD. https://www.pharmacytimes.com/view/new-drug-overview-aducanumab-avwa-aduhelm-for-alzheimer-disease November 4, 2021.
  
• Colquitt C, Jones JD, Jackson SH. Analysis of Novel Anticoagulants for Atrial Fibrillation – Pharmacokinetics and Pharmacological Considerations. Cardiology and Angiology: An International Journal 2(4): 278-292, 2014, Article no.CA.2014.4.013.
  
• Jones JD, Jackson SH, Colquitt C. Azilsartan alone and in combination for the treatment of hypertension-clinical utility and patient considerations. Research Reports in Clinical Cardiology 2013:4;125–133.
  
• Jones JD, Jackson SH, Agboton C, Martin TS. Azilsartan (Edarbi): The eighth angiotensin II receptor blocker. PT. 2011 Oct; 36(10): 634-640.
  
• Jones JD, Jackson SH, Gomez A, Hollinger C, Rivers G. Evaluation of Pharmacy Students’ Clinical Interventions on a General Medicine Practice Experience. Pharmacy Practice 2011; 9(1): 11-15.
  
• Jackson SH, Martin TS, Jones JD, Seal D, Emanuel FS. Liraglutide (Victoza) The First Once-Daily Incretin Mimetic Injection for Type 2 Diabetes. PT. 2010 Sept; 35(9): 498-502.
  
• Jones JD, ter Riet L, Andrews C, Powell M, Williams L, Emanuel F. Goal Attainment in Patients with Type 2 Diabetes. Part 2. Fed Prac. 2008;(25) 8:14-25.
•  Jones JD, ter Riet L, Andrews C, Powell M, Williams L, Emanuel F. Goal Attainment in Patients with Type 2 Diabetes. Part 1. Fed Prac. 2008;(25) 8:13-18.
  
• Jones JD, King KD, Emanuel FS. Hypertension: A Clinical Pharmacist’s Synopsis of JNC 7. Am J Pharm Educ. 2004; 68(3) Article 71.
  
• King KD, Jones JD. Microvascular and Macrovascular Complications of Diabetic Mellitus. Am J Pharm Educ. 2005; 69(5) Article 87.
  
• Thornton A, Honeywell M, LeBron AL, Henderson A, Jones JD. Understanding Treatment Options for Psoriasis. US Pharm. April 2004.

---

---

• Girl Scouts of America, Woman of Distinction, 2020
  
• Executive Associate Dean Appreciation Award, Florida A&M University College of Pharmacy and
  Pharmaceutical Sciences, 2018
  
• Dean’s Appreciation Award, Florida A&M University College of Pharmacy and Pharmaceutical
  Sciences, 2014
  
• Teacher of the Year, Florida A&M University College of Pharmacy and
  Pharmaceutical Sciences, 2012
  
• Tenured and promoted to Associate Professor, 2009
  
• Shands Jacksonville Medical Center Brown Bag Recognition, 2008
  
• Teacher of the Year, Florida A&M University College of Pharmacy and
  Pharmaceutical Sciences, Jacksonville Instructional Site, 2007
  
• Teacher of the Year, Florida A&M University College of Pharmacy and
  Pharmaceutical Sciences Jacksonville Instructional Site, 2003

---

---

• PHA 3884 Pharmacy Forum and Colloquium
  
• PHA 4886 Pharmacy Forum and Colloquium
  
• PHA 5888 Pharmacy Forum and Colloquium
  
• PHA 3885 Pharmacy Forum and Colloquium
  
• PHA 4887 Pharmacy Forum and Colloquium
  
• PHA 5889 Pharmacy Forum and Colloquium
  
• PHA 4615 Patient Care I
  
• PHA 4615L Patient Care I Lab